View Document Preview and Link Document Date: 2014-06-30 08:19:59 Open Document File Size: 42,10 KB Share Result on Facebook
City S Hynes III / / Company ELI LILLY AUST PTY LTD / D.T. Wong N.A. / Lilly / R.W.Fuller 15639 S L.C. / Elite Pharmaceuticals Inc. / / Country Germany / France / United Kingdom / / Currency pence / / Event FDA Phase / / Facility Laboratory Animals / / IndustryTerm hydrochloride tablet product / human product / non-food producing species / human pharmaceutical / secondary applications / / MedicalCondition chronic toxicity / dermatitis / muscle tremors / acral lick dermatitis / lethargy / mydriasis / seizure / muscle tremor / separation anxiety / morphine hypothermia / canine separation anxiety / constipation / human volunteers Chronic / Obsessive-Compulsive Disorder / / MedicalTreatment First Aid / / Organization office of Chemical Safety / Dept of Health / National Drugs and Poisons Schedule Committee / Australian Government Department of Health And Ageing / Department of the Environment / Department of Health / Department of the Environment / Water / Heritage and the Arts / / Person Perry J.L. Rapoport / / Position Author / veterinarian / Governor / prescribing veterinarian / / Product Fluoxetine / CHEWABLE TABLETS / Tricyclic Antidepressant / Reconcile Chewable Tablets / fluoxetine hydrochloride / clomipramine hydrochloride / RECONCILE CHEWABLE TABLETS FOR DOGS / Reconcile / / ProvinceOrState Maryland / / Technology Pharmacokinetics / / URL http / SocialTag 
Advice Summary - Product No[removed], Application No[removed]